Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

Jonathan O’B Hourihane, Kirsten Beyer, Allyah Abbas‐Hanif, Montserrat Fernández‐Rivas, Paul Turner, Katharina Blümchen, Caroline Nilsson, María Dolores Ibáñez, A. Deschildre, Antonella Muraro, Vibha Sharma, Michel Erlewyn‐Lajeunesse, José Manuel Zubeldia, F. de Blay, Christine Sauvage, Aideen Byrne, John Chapman, F. Boralévi, Audrey DunnGalvin, Charmaine O'Neill, David Norval, Andrea Vereda, Ben Skeel, Daniel C. Adelman, George Du Toit